Morgan Stanley Boosts Anthem (ANTM) Price Target to $266.00

Anthem (NYSE:ANTM) had its target price upped by analysts at Morgan Stanley from $247.00 to $266.00 in a research note issued to investors on Thursday. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price objective suggests a potential upside of 9.05% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the stock. ValuEngine upgraded shares of Anthem from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. B. Riley restated a “buy” rating on shares of Anthem in a report on Wednesday, December 6th. Bank of America raised their price objective on shares of Anthem from $249.00 to $254.00 and gave the company a “buy” rating in a research note on Friday, November 17th. BidaskClub raised shares of Anthem from a “hold” rating to a “buy” rating in a research note on Thursday, October 26th. Finally, Cantor Fitzgerald reaffirmed a “buy” rating and issued a $220.00 price objective on shares of Anthem in a research note on Wednesday, October 25th. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Anthem has an average rating of “Buy” and an average target price of $226.94.

Anthem (ANTM) traded down $3.92 during trading hours on Thursday, reaching $243.93. 1,988,836 shares of the company’s stock were exchanged, compared to its average volume of 1,480,000. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.51 and a quick ratio of 1.51. The firm has a market capitalization of $62,630.00, a PE ratio of 16.99, a price-to-earnings-growth ratio of 1.68 and a beta of 0.79. Anthem has a 1-year low of $154.37 and a 1-year high of $267.95.

Anthem (NYSE:ANTM) last posted its quarterly earnings results on Wednesday, January 31st. The company reported $1.29 EPS for the quarter, topping analysts’ consensus estimates of $1.25 by $0.04. The business had revenue of $22.45 billion during the quarter, compared to analysts’ expectations of $22.17 billion. Anthem had a net margin of 3.35% and a return on equity of 12.97%. The business’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the company posted $1.76 earnings per share. research analysts forecast that Anthem will post 11.97 EPS for the current year.

Anthem declared that its board has authorized a share repurchase plan on Thursday, December 7th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

In related news, EVP Gloria M. Mccarthy sold 14,429 shares of the firm’s stock in a transaction dated Thursday, January 4th. The shares were sold at an average price of $229.68, for a total transaction of $3,314,052.72. Following the transaction, the executive vice president now directly owns 30,667 shares of the company’s stock, valued at $7,043,596.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Joseph Swedish sold 67,500 shares of the firm’s stock in a transaction dated Thursday, January 11th. The shares were sold at an average price of $235.87, for a total transaction of $15,921,225.00. Following the transaction, the insider now directly owns 134,043 shares in the company, valued at $31,616,722.41. The disclosure for this sale can be found here. Insiders have sold 105,634 shares of company stock worth $24,682,425 over the last three months. 0.36% of the stock is owned by insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. C M Bidwell & Associates Ltd. lifted its position in shares of Anthem by 0.5% during the second quarter. C M Bidwell & Associates Ltd. now owns 1,070 shares of the company’s stock valued at $201,000 after purchasing an additional 5 shares in the last quarter. Gofen & Glossberg LLC IL lifted its position in shares of Anthem by 0.6% during the second quarter. Gofen & Glossberg LLC IL now owns 2,540 shares of the company’s stock valued at $478,000 after purchasing an additional 15 shares in the last quarter. Sii Investments Inc. WI lifted its position in shares of Anthem by 5.4% during the second quarter. Sii Investments Inc. WI now owns 2,860 shares of the company’s stock valued at $537,000 after purchasing an additional 147 shares in the last quarter. Cubist Systematic Strategies LLC lifted its position in shares of Anthem by 4.3% during the second quarter. Cubist Systematic Strategies LLC now owns 4,682 shares of the company’s stock valued at $881,000 after purchasing an additional 194 shares in the last quarter. Finally, FineMark National Bank & Trust lifted its position in shares of Anthem by 8.3% during the fourth quarter. FineMark National Bank & Trust now owns 2,933 shares of the company’s stock valued at $660,000 after purchasing an additional 225 shares in the last quarter. 87.52% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by American Banking and Market News and is the sole property of of American Banking and Market News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/01/morgan-stanley-boosts-anthem-antm-price-target-to-266-00.html.

Anthem Company Profile

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

Analyst Recommendations for Anthem (NYSE:ANTM)